ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,736Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 944

$713K Total Retail Price of All Prescriptions

Rank: 64 out of 944

560 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 694 656 1 1
WARFARIN SODIUM 571 546 2 7
LISINOPRIL 507 487 3 3
LEVOTHYROXINE SODIUM 457 431 4 2
HYDROCHLOROTHIAZIDE 444 419 5 9
FUROSEMIDE 408 364 6 6
AMLODIPINE BESYLATE 347 334 7 5
OMEPRAZOLE 330 313 8 4
ATENOLOL 306 294 9 11
METOPROLOL SUCCINATE 237 237 10 14
METOPROLOL TARTRATE 223 223 11 8
GLYBURIDE 203 182 R 12 63
LOVASTATIN 202 201 13 26
LOSARTAN POTASSIUM 199 191 14 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 190 180 15 29
CRESTOR 185 179 16 28
DONEPEZIL HCL 176 176 17 24
ATORVASTATIN CALCIUM 171 161 18 13
DIOVAN 155 142 19 38
GABAPENTIN 154 146 20 18
HYDROCODONE-ACETAMINOPHEN 153 133 S3 21 10
METFORMIN HCL ER 137 118 22 49
CARVEDILOL 133 126 23 30
LOSARTAN-HYDROCHLOROTHIAZIDE 131 124 24 54
CITALOPRAM HBR 123 112 25 19
SERTRALINE HCL 116 111 26 23
HUMALOG 116 99 26 109
TAMSULOSIN HCL 110 107 28 27
DOXAZOSIN MESYLATE 109 106 29 60
ZOLPIDEM TARTRATE 107 84 30 25
ADVAIR DISKUS 106 89 31 31
PANTOPRAZOLE SODIUM 104 90 32 34
DILTIAZEM ER 103 103 33 88
ALLOPURINOL 98 98 34 22
CLOPIDOGREL 96 95 35 36
METFORMIN HCL 89 73 36 12
LANTUS SOLOSTAR 88 88 37 61
DIOVAN HCT 88 88 37 108
CLONIDINE HCL 87 81 39 67
SYNTHROID 86 73 40 82
PREDNISONE 86 84 40 32
ISOSORBIDE MONONITRATE ER 80 80 42 52
LANTUS 77 70 43 46
POTASSIUM CHLORIDE 76 76 44 15
NAMENDA 73 73 45 37
PRAVASTATIN SODIUM 70 70 46 17
KLOR-CON M20 68 68 47 71
BENAZEPRIL HCL 68 60 47 66
DIGOXIN 67 67 49 39
ALENDRONATE SODIUM 65 65 50 20
NEXIUM 64 55 51 53
SPIRONOLACTONE 64 62 51 44
TRAMADOL HCL 62 47 53 21
PROAIR HFA 62 56 53 56
INDAPAMIDE 58 58 55 130
RANITIDINE HCL 58 51 55 42
FENOFIBRATE 58 44 55 58
VENLAFAXINE HCL ER 56 44 58 84
AZITHROMYCIN 50 44 59 70
PLAVIX 50 50 59 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.